Saturday 17 October 2026
Export NSRX’s income statement to Excel — free account
Nasus Pharma Ltd.
NSRX Healthcare Drug Manufacturers General
Insiders bought in the last twelve months.
3.18
0.01
+0.32%
Follow NSRX
Nasus Pharma Ltd. (NSRX) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MIRA MIRA Pharmaceuticals, Inc. compare | n/m |
| MDCX Medicus Pharma Ltd compare | n/m |
| SCLX Scilex Holding Company compare | n/m |
| AMRN Amarin Corporation PLC compare | n/m |
| GRFS Grifols, S.A. compare | 8.5× |
| OGN Organon & Co. compare | 17.4× |
| SNY Sanofi compare | 21.3× |
| BIIB Biogen Inc. compare | 41.0× |
| NSRX Nasus Pharma Ltd. | — |
| Drug Manufacturers General industry median | 24.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)